LabCorp supports drug approvals by FDA.
5 reports, 2 independent
Updated Aug 28
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 5
- Developments
- 1
- Repetition
- 80%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
LabCorp supports drug approvals by FDA.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- FDA approval is the goal for product candidates from Daré Bioscience, Inc.
- Bank of America boosted LabCorp's target price.
- The FDA is involved in regulating drug approvals for GLP-1 Receptor Agonists.
- FDA approved a drug based on UVA research led by Xuemei Huang.
- ADC Therapeutics received accelerated approval for its drug from the FDA.
Coverage
Newest first; wire copies grouped- PR NewswireLabcorp to Speak at the Morgan Stanley 23rd Annual Global Healthcare Conference BURLINGTON, N.C., Aug. 27, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive lab
- StockStoryQ2 Earnings Outperformers: Labcorp (NYSE:LH) And The Rest Of The Testing & Diagnostics Services Stocks The end of an earnings season can be a great time to discover new stocks and assess how companie
- StockStory1 Mooning Stock Worth Investigating and 2 Facing Challenges The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong busin
- PR NewswireLabcorp Declares Quarterly Dividend BURLINGTON, N.C., July 10, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced to